These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 19215987)

  • 1. Patterns of major depression and drug-related problems amongst heroin users across 36 months.
    Darke S; Mills K; Teesson M; Ross J; Williamson A; Havard A
    Psychiatry Res; 2009 Mar; 166(1):7-14. PubMed ID: 19215987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
    Ross J; Teesson M; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Rev; 2005 Sep; 24(5):411-8. PubMed ID: 16298835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
    Darke S; Hetherington K; Ross J; Lynskey M; Teesson M
    Drug Alcohol Rev; 2004 Jun; 23(2):177-83. PubMed ID: 15370024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between cocaine use and short-term outcomes for the treatment of heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Williamson A; Darke S; Ross J; Teesson M
    Drug Alcohol Rev; 2006 Mar; 25(2):141-8. PubMed ID: 16627303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates.
    Mills KL; Lynskey M; Teesson M; Ross J; Darke S
    Drug Alcohol Depend; 2005 Mar; 77(3):243-9. PubMed ID: 15734224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Mills K; Ross J; Darke S; Williamson A; Havard A
    Addiction; 2008 Jan; 103(1):80-8. PubMed ID: 17995994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after detoxification for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Havard A; Ross J; Darke S
    Drug Alcohol Rev; 2006 May; 25(3):241-7. PubMed ID: 16753648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
    Teesson M; Ross J; Darke S; Lynskey M; Ali R; Ritter A; Cooke R
    Drug Alcohol Depend; 2006 Jun; 83(2):174-80. PubMed ID: 16343809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns and correlates of attempted suicide by heroin users over a 3-year period: findings from the Australian treatment outcome study.
    Darke S; Ross J; Williamson A; Mills KL; Havard A; Teesson M
    Drug Alcohol Depend; 2007 Mar; 87(2-3):146-52. PubMed ID: 16971060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence.
    Darke S; Ross J; Williamson A; Teesson M
    Addiction; 2005 Aug; 100(8):1121-30. PubMed ID: 16042642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression among heroin users: 12-Month outcomes from the Australian Treatment Outcome Study (ATOS).
    Havard A; Teesson M; Darke S; Ross J
    J Subst Abuse Treat; 2006 Jun; 30(4):355-62. PubMed ID: 16716851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
    Darke S; Ross J; Lynskey M; Teesson M
    Drug Alcohol Depend; 2004 Jan; 73(1):1-10. PubMed ID: 14687954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of sustained heroin abstinence amongst long-term, dependent heroin users: 36 months findings from the Australian Treatment Outcome Study (ATOS).
    Darke S; Ross J; Mills KL; Williamson A; Havard A; Teesson M
    Addict Behav; 2007 Sep; 32(9):1897-906. PubMed ID: 17289282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study.
    Williamson A; Darke S; Ross J; Teesson M
    J Subst Abuse Treat; 2007 Oct; 33(3):287-93. PubMed ID: 17889301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS).
    Darke S; Williamson A; Ross J; Teesson M
    Drug Alcohol Depend; 2005 May; 78(2):177-86. PubMed ID: 15845321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes and predictors of change in the physical health status of heroin users over 24 months.
    Williamson A; Darke S; Ross J; Teesson M
    Addiction; 2009 Mar; 104(3):465-70. PubMed ID: 19207357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with methadone maintenance therapy use among a cohort of polysubstance using injection drug users in Vancouver.
    Kerr T; Marsh D; Li K; Montaner J; Wood E
    Drug Alcohol Depend; 2005 Dec; 80(3):329-35. PubMed ID: 15964714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of drug use and associated harms among rural injecting drug users: comparisons with metropolitan injecting drug users.
    Day C; Conroy E; Lowe J; Page J; Dolan K
    Aust J Rural Health; 2006 Jun; 14(3):120-5. PubMed ID: 16706881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.